- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Basis and Therapies for Vascular Anomalies
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 129, Issue 1, Pages 155-173
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-06-25
DOI
10.1161/circresaha.121.318145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
- (2021) Karina Forde et al. Orphanet Journal of Rare Diseases
- Genetic Basis and Therapies for Vascular Anomalies
- (2021) Angela Queisser et al. CIRCULATION RESEARCH
- Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases
- (2020) Ruicheng Tian et al. JOURNAL OF PEDIATRIC SURGERY
- Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series
- (2020) Priscila Badia et al. PEDIATRIC BLOOD & CANCER
- Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series
- (2020) Melissa Dodds et al. PEDIATRIC DERMATOLOGY
- Theranostic Advances in Vascular Malformations
- (2020) Valérie Dekeuleneer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- New and Emerging Targeted Therapies for Vascular Malformations
- (2020) An Van Damme et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications
- (2020) Calver Pang et al. VASCULAR MEDICINE
- Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
- (2020) Ines Martinez-Corral et al. Nature Communications
- AKT/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations
- (2020) Yameng Si et al. Cell Communication and Signaling
- Kaposiform lymphangiomatosis effectively treated with MEK inhibition
- (2020) Jessica B Foster et al. EMBO Molecular Medicine
- Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation
- (2019) Xian Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A somatic missense mutation in GNAQ causes capillary malformation
- (2019) Colette Bichsel et al. CURRENT OPINION IN HEMATOLOGY
- PIK3CA mutations in vascular malformations
- (2019) Sandra D. Castillo et al. CURRENT OPINION IN HEMATOLOGY
- Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review
- (2019) Sameer D. Kini et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- RASA1 mosaic mutations in patients with capillary malformation-arteriovenous malformation
- (2019) Nicole Revencu et al. JOURNAL OF MEDICAL GENETICS
- ALPELISIB TREATMENT FOR GENITAL VASCULAR MALFORMATION IN CLOVES SYNDROME
- (2019) Juan Carlos López Gutiérrez et al. Journal of Pediatric and Adolescent Gynecology
- ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
- (2019) Dong Li et al. NATURE MEDICINE
- PTEN Hamartoma Tumor Syndrome: A Clinical Overview
- (2019) Robert Pilarski Cancers
- Congenital Lymphatic Malformation and Aortic Aneurysm in a Patient with TSC2 Mutation
- (2019) Adelheid Wiemer-Kruel et al. NEUROPEDIATRICS
- Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
- (2019) Michio Ozeki et al. Orphanet Journal of Rare Diseases
- FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
- (2019) Andreas Hähle et al. PLoS One
- Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review
- (2019) Cristiana Freixo et al. JOURNAL OF VASCULAR SURGERY
- Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review
- (2018) Ashleigh A. Halderman et al. American Journal of Rhinology & Allergy
- Somatic NRAS mutation in patient with generalized lymphatic anomaly
- (2018) Eugenia Manevitz-Mendelson et al. ANGIOGENESIS
- Development of Molecular Therapies for Venous Malformations
- (2018) Jaakko Kangas et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
- (2018) C. Ranieri et al. NEUROGENETICS
- Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
- (2018) Sergey I. Nikolaev et al. NEW ENGLAND JOURNAL OF MEDICINE
- Etiology and Genetics of Congenital Vascular Lesions
- (2018) Angela Queisser et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model
- (2018) Wan Zhu et al. STROKE
- PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations
- (2018) Laura di Blasio et al. Cell Death & Disease
- Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
- (2018) Victoria E. R. Parker et al. GENETICS IN MEDICINE
- The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review
- (2018) L Harrison et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Targeted therapy in patients with PIK3CA-related overgrowth syndrome
- (2018) Quitterie Venot et al. NATURE
- Intranasal bevacizumab in the treatment of HHT -related epistaxis: a systematic review
- (2018) P Stokes et al. RHINOLOGY
- A somatic activating NRAS variant associated with kaposiform lymphangiomatosis
- (2018) Sarah F. Barclay et al. GENETICS IN MEDICINE
- Therapeutic approaches to pyogenic granuloma: an updated review
- (2018) Kerasia-Maria Plachouri et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
- (2018) Lara Al-Olabi et al. JOURNAL OF CLINICAL INVESTIGATION
- Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
- (2018) Jennifer Hammer et al. Orphanet Journal of Rare Diseases
- Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child
- (2018) Ramrada Lekwuttikarn et al. JAMA Dermatology
- Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
- (2017) Tomoyuki Mizuno et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation
- (2017) Eun Jin Doh et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations
- (2017) Julie Soblet et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies
- (2017) Tomoyuki Mizuno et al. PEDIATRIC BLOOD & CANCER
- Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review
- (2016) M Nadal et al. ACTA DERMATO-VENEREOLOGICA
- GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation
- (2016) Young H. Lim et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma
- (2016) Ugur M. Ayturk et al. AMERICAN JOURNAL OF HUMAN GENETICS
- RASA1somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome
- (2016) Colleen F. Macmurdo et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma
- (2016) Leopold Groesser et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The pathobiology of vascular malformations: insights from human and model organism genetics
- (2016) Sarah E Wetzel-Strong et al. JOURNAL OF PATHOLOGY
- Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon
- (2016) Hideki Matsumoto et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial
- (2016) Karin Greveling et al. LASERS IN SURGERY AND MEDICINE
- Cerebral cavernous malformations arise from endothelial gain of MEKK3–KLF2/4 signalling
- (2016) Zinan Zhou et al. NATURE
- Everolimus for Primary Intestinal Lymphangiectasia With Protein-Losing Enteropathy
- (2016) Michio Ozeki et al. PEDIATRICS
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
- (2016) D. M. Adams et al. PEDIATRICS
- Inheritance Patterns of Infantile Hemangioma
- (2016) Eeva Castrén et al. PEDIATRICS
- Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
- (2016) Sandra D. Castillo et al. Science Translational Medicine
- Somatic PIK3CA mutations as a driver of sporadic venous malformations
- (2016) Pau Castel et al. Science Translational Medicine
- PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia
- (2016) Roxana Ola et al. Nature Communications
- Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11
- (2016) Tracy Funk et al. JAMA Dermatology
- Somatic Activating PIK3CA Mutations Cause Venous Malformation
- (2015) Nisha Limaye et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Somatic MAP3K3 Mutation Is Associated with Verrucous Venous Malformation
- (2015) Javier A. Couto et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
- (2015) Lauren M. Hare et al. DEVELOPMENTAL BIOLOGY
- Sirolimus for the treatment of children with various complicated vascular anomalies
- (2015) Herwig Lackner et al. EUROPEAN JOURNAL OF PEDIATRICS
- Common and specific effects of TIE2 mutations causing venous malformations
- (2015) Marjut Nätynki et al. HUMAN MOLECULAR GENETICS
- Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects
- (2015) Elisa Boscolo et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic Activating RAS Mutations Cause Vascular Tumors Including Pyogenic Granuloma
- (2015) Young H. Lim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment
- (2015) Thomas D. Griffin et al. LASERS IN SURGERY AND MEDICINE
- Clinical delineation and natural history of thePIK3CA-related overgrowth spectrum
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations
- (2014) Alexander J. Osborn et al. HUMAN MOLECULAR GENETICS
- Successful treatment of kaposiform hemangioendothelioma with everolimus
- (2014) Teruaki Uno et al. PEDIATRIC BLOOD & CANCER
- Focus on mTOR inhibitors and tacrolimus in renal transplantation: Pharmacokinetics, exposure–response relationships, and clinical outcomes
- (2014) Fuad Shihab et al. TRANSPLANT IMMUNOLOGY
- Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations
- (2013) Mustapha Amyere et al. AMERICAN JOURNAL OF HUMAN GENETICS
- BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia
- (2013) Whitney L. Wooderchak-Donahue et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB
- (2013) Melanie Uebelhoer et al. HUMAN MOLECULAR GENETICS
- RASA1Mutations and Associated Phenotypes in 68 Families with Capillary Malformation-Arteriovenous Malformation
- (2013) Nicole Revencu et al. HUMAN MUTATION
- CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling
- (2013) Eva Faurobert et al. JOURNAL OF CELL BIOLOGY
- Partially involuting congenital hemangiomas: A report of 8 cases and review of the literature
- (2013) Eiman Nasseri et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Mechanism for KRIT1 Release of ICAP1-Mediated Suppression of Integrin Activation
- (2013) Weizhi Liu et al. MOLECULAR CELL
- Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ
- (2013) Matthew D. Shirley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation
- (2013) Shailee Lala et al. SKELETAL RADIOLOGY
- Vascular Anomalies: From Genetics toward Models for Therapeutic Trials
- (2013) M. Uebelhoer et al. Cold Spring Harbor Perspectives in Medicine
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
- (2012) Kyle C. Kurek et al. AMERICAN JOURNAL OF HUMAN GENETICS
- EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner
- (2012) Zhan Xiao et al. CANCER BIOLOGY & THERAPY
- The genetics of vascular anomalies
- (2012) Alice Frigerio et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
- (2012) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
- (2012) Jean-Baptiste Rivière et al. NATURE GENETICS
- Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain
- (2012) Espen J. Walker et al. STROKE
- Sirolimus for the treatment of complicated vascular anomalies in children
- (2011) Adrienne M. Hammill et al. PEDIATRIC BLOOD & CANCER
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
- (2010) Franck Lebrin et al. NATURE MEDICINE
- Diagnosis and management of hemangiomas and vascular malformations of the head and neck
- (2010) LM Buckmiller et al. ORAL DISEASES
- Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling
- (2010) Joycelyn Wüstehube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Signaling mechanisms in infantile hemangioma
- (2009) Eileen Boye et al. CURRENT OPINION IN HEMATOLOGY
- Head and neck vascular anomalies in children
- (2009) Filippo Maria Tucci et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations
- (2009) J Sirvente et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
- (2009) H. T. Yuan et al. MOLECULAR AND CELLULAR BIOLOGY
- Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
- (2008) Nicole Revencu et al. HUMAN MUTATION
- Infantile Hemangiomas: An Emerging Health Issue Linked to an Increased Rate of Low Birth Weight Infants
- (2008) Beth A. Drolet et al. JOURNAL OF PEDIATRICS
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations
- (2008) Nisha Limaye et al. NATURE GENETICS
- Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
- (2008) Masatoshi Jinnin et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now